These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
659 related items for PubMed ID: 28274272
1. The method of detection of ductal carcinoma in situ has no therapeutic implications: results of a population-based cohort study. Elshof LE, Schaapveld M, Rutgers EJ, Schmidt MK, de Munck L, van Leeuwen FE, Wesseling J. Breast Cancer Res; 2017 Mar 09; 19(1):26. PubMed ID: 28274272 [Abstract] [Full Text] [Related]
3. Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women. Elshof LE, Schaapveld M, Schmidt MK, Rutgers EJ, van Leeuwen FE, Wesseling J. Breast Cancer Res Treat; 2016 Oct 09; 159(3):553-63. PubMed ID: 27624164 [Abstract] [Full Text] [Related]
8. Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study. Duffy SW, Dibden A, Michalopoulos D, Offman J, Parmar D, Jenkins J, Collins B, Robson T, Scorfield S, Green K, Hall C, Liao XH, Ryan M, Johnson F, Stevens G, Kearins O, Sellars S, Patnick J. Lancet Oncol; 2016 Jan 09; 17(1):109-14. PubMed ID: 26655422 [Abstract] [Full Text] [Related]
9. The distribution of ductal carcinoma in situ (DCIS) grade in 4232 women and its impact on overdiagnosis in breast cancer screening. van Luijt PA, Heijnsdijk EA, Fracheboud J, Overbeek LI, Broeders MJ, Wesseling J, den Heeten GJ, de Koning HJ. Breast Cancer Res; 2016 May 10; 18(1):47. PubMed ID: 27160733 [Abstract] [Full Text] [Related]
10. Risk of subsequent invasive breast cancer after a diagnosis of ductal carcinoma in situ (DCIS). Cheung S, Booth ME, Kearins O, Dodwell D. Breast; 2014 Dec 10; 23(6):807-11. PubMed ID: 25270228 [Abstract] [Full Text] [Related]
12. The frequency of presentation and clinico-pathological characteristics of symptomatic versus screen detected ductal carcinoma in situ of the breast. Barnes NL, Dimopoulos N, Williams KE, Howe M, Bundred NJ. Eur J Surg Oncol; 2014 Mar 10; 40(3):249-54. PubMed ID: 24433818 [Abstract] [Full Text] [Related]
14. A comparison of two models for breast cancer mortality for women with ductal carcinoma in situ: an SEER-based analysis. Giannakeas V, Sopik V, Narod SA. Breast Cancer Res Treat; 2018 Jun 10; 169(3):587-594. PubMed ID: 29445939 [Abstract] [Full Text] [Related]
15. Long-term Surveillance of Ductal Carcinoma in Situ Detected with Screening Mammography versus US: Factors Associated with Second Breast Cancer. Choi SH, Choi JS, Han BK, Ko EY, Ko ES, Park KW. Radiology; 2019 Jul 10; 292(1):37-48. PubMed ID: 31038406 [Abstract] [Full Text] [Related]
16. The effects of contemporary treatment of DCIS on the risk of developing an ipsilateral invasive Breast cancer (iIBC) in the Dutch population. Alaeikhanehshir S, Schmitz RSJM, van den Belt-Dusebout AW, van Duijnhoven FH, Verschuur E, van Seijen M, Schaapveld M, Lips EH, Wesseling J, and Grand Challenge PRECISION Consortium. Breast Cancer Res Treat; 2024 Feb 10; 204(1):61-68. PubMed ID: 37964135 [Abstract] [Full Text] [Related]
19. Characteristics and behaviour of screen-detected ductal carcinoma in situ of the breast: comparison with symptomatic patients. Koh VC, Lim JC, Thike AA, Cheok PY, Thu MM, Tan VK, Tan BK, Ong KW, Ho GH, Tan WJ, Tan Y, Salahuddin AS, Busmanis I, Chong AP, Iqbal J, Thilagaratnam S, Wong JS, Tan PH. Breast Cancer Res Treat; 2015 Jul 10; 152(2):293-304. PubMed ID: 26077641 [Abstract] [Full Text] [Related]
20. Second events following ductal carcinoma in situ of the breast: a register-based cohort study. Falk RS, Hofvind S, Skaane P, Haldorsen T. Breast Cancer Res Treat; 2011 Oct 10; 129(3):929-38. PubMed ID: 21537936 [Abstract] [Full Text] [Related] Page: [Next] [New Search]